Cargando…
Type I Interferons and Natural Killer Cell Regulation in Cancer
Type I interferons (IFNs) are known to mediate antitumor effects against several tumor types and have therefore been commonly used in clinical anticancer treatment. However, how IFN signaling exerts its beneficial effects is only partially understood. The clinically relevant activity of type I IFNs...
Autores principales: | Müller, Lena, Aigner, Petra, Stoiber, Dagmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374157/ https://www.ncbi.nlm.nih.gov/pubmed/28408907 http://dx.doi.org/10.3389/fimmu.2017.00304 |
Ejemplares similares
-
Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells
por: Barnes, Samantha A., et al.
Publicado: (2022) -
Natural Killer Cells as Key Mediators in Type I Diabetes Immunopathology
por: Gardner, Graeme, et al.
Publicado: (2021) -
Obesity-Associated Alterations of Natural Killer Cells and Immunosurveillance of Cancer
por: Bähr, Ina, et al.
Publicado: (2020) -
The Dual Nature of Type I and Type II Interferons
por: Lee, Amanda J., et al.
Publicado: (2018) -
Fra-2 Is a Dominant Negative Regulator of Natural Killer Cell Development
por: Schnoegl, Diana, et al.
Publicado: (2022)